The patient will be asked to sit or lie in a comfortable position to relax the muscles
Kossoy G, Anisimov VN, Ben-Hur H, Kossoy N, Zusman I
Record infusion start and stop times, medication name, dose, route, indication, infusion type (initial, sequential, concurrent), and clinician signature
It is not produced by our bodies and must be obtained through meals such as meat, fish, milk, and eggs
Phase Initial 4 weeks Daily Dose 300 mcg Volume 0.18 mL Units (U-100) 18 units Phase Maintenance (weeks 5-12) Daily Dose 500 mcg Volume 0.30 mL Units (U-100) 30 units Phase Optional extension Daily Dose 300-500 mcg Volume 0.18-0.30 mL Units (U-100) 18-30 units This summarizes the published research-context dose range (commonly cited 300-500 mcg/day)
Note: This example uses a standard 10 mg retatrutide vial